Biointron, a Chinese contract research organisation (CRO) that serves life science researchers and biopharmaceutical companies, has secured almost 500 million yuan ($72.4 million) in a Series B funding round to expand its operations.
Continue reading with Data Vantage
Venture-backed company data in SE Asia, India, Pakistan, Bangladesh.
Instant investment updates and valuations.
Tailored search, 3 monthly reports.
Industry-trusted platform.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com